monkeypox warnings ignored; Dominant COVID Strain Emerges; Better Paxlovid access

Note that some links may require registration or subscription.

Warning signs from the current monkeypox outbreak may have been ignored. (STAT)

The CDC issued a monkeypox travel advisory calling for “enhanced precautions” after cases were reported in North America, Europe and Australia.

Roche announced that it has developed three PCR test kits for the detection of monkeypox virus.

The US has a new dominant COVID-19 strain – BA.2.12.1 – a highly contagious sublineage of the BA.2 omicron subvariant that now accounts for 57.9% of all cases, according to CDC estimates.

Washington Governor Jay Inslee and Lt. gov. Denny Heck both tested positive for COVID-19, as did US Rep. Liz Cheney (R-Wyo.). (Seattle Times, The hill)

As of 8:00 a.m. EDT Thursday, the unofficial U.S. COVID toll stood at 83,697,199 cases and 1,004,558 deaths, an increase of 218,146 and 913, respectively, compared to this time Wednesday morning.

The Biden administration, expecting COVID infections to continue to spread during the summer travel season, announced additional steps to make nirmatrelvir/ritonavir (Paxlovid) more accessible. (abc news)

The White House also announced the launch of the first federally-sponsored test-to-treat COVID site.

British Prime Minister Boris Johnson and other senior leaders are responsible for alcohol-filled parties that broke the country’s COVID-19 lockdown rules, according to an investigative report. (NPR)

A mouse study suggested that maraviroc (Selzentry), an FDA-approved drug used to treat HIV, may be able to reverse memory loss in middle age. (Nature)

The University of California system is paying nearly $700 million to women who said they were sexually abused by a UCLA gynecologist over the course of several decades. (AP)

The parents of a 4-year-old girl spoke about her mysterious case of pediatric hepatitis that required a liver transplant, one of 180 similar cases being investigated in the US (today)

Teva Pharmaceuticals has issued a voluntary nationwide recall of a lot of anagrelide capsules, used to treat thrombocythemia secondary to myeloproliferative neoplasms, due to failure of dissolution testing during routine stability testing.

Dienst announced FDA approval of ivosidenib (Tibsovo) in combination with azacitidine for certain patients with newly diagnosed acute myeloid leukemia with IDH1 mutation.

A report by the American Medical Association shows payers are not following prior approval reforms agreed in 2018. (Fierce Healthcare)

The mass shooting in Buffalo earlier this month is a reminder that millions of Americans don’t have easy access to grocery stores. (NPR)

COVID-era misinformation is leading a wave of parents to reject ordinary childhood vaccinations. (New York Times)

The FDA has issued guidance with rules for states wishing to import certain prescription drugs from Canada.

  • Mike Bassett is a staff writer focused on oncology and hematology. He lives in Massachusetts.

Leave a Comment